Results 21 to 30 of about 208,963 (249)

Leishmaniasis in the United States: Emerging Issues in a Region of Low Endemicity

Microorganisms, 2021
Leishmaniasis, a chronic and persistent intracellular protozoal infection caused by many different species within the genus Leishmania, is an unfamiliar disease to most North American providers.
John M. Curtin, Naomi E. Aronson
doaj   +1 more source

Leishmaniasis: new approaches to disease control. [PDF]

, 2003
The leishmaniases afflict the world's poorest populations. Among the two million new cases each year in the 88 countries where the disease is endemic (fig 1), it is estimated that 80% earn less than $2 a day.
Croft, Simon L, Davies, Clive R, Kaye, Paul, Sundar, Shyam   +3 more
core   +2 more sources

Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an Ethiopian population with high HIV prevalence. [PDF]

, 2011
Due to unacceptably high mortality with pentavalent antimonials, Médecins Sans Frontières in 2006 began using liposomal amphotericin B (AmBisome) for visceral leishmaniasis (VL) patients in Ethiopia who were severely ill or positive for human ...
Aderie, Endashaw Mengistu, Chane, Solomon, Collin, Simon M, Davidson, Robert N, Piening, Turid, Ritmeijer, Koert, ter Horst, Rachel   +6 more
core   +2 more sources

Treatment of visceral leishmaniasis

Journal of Global Infectious Diseases, 2010
The available treatment options for visceral leishmaniasis (VL) have problems relating to efficacy, adverse effects and cost, making treatment a complex issue. We review the evidence relating to the different methods of treatment in relation to - efficacy and toxicity of the drugs in different areas of the world; ability to monitor side effects, length
Diana N. J. Lockwood, EM Moore
openaire   +4 more sources

Visceral Leishmaniasis in Dogs [PDF]

Acta Scientiae Veterinariae, 2021
Background: Canine visceral leishmaniasis (CVL) is a zoonosis of variable clinical presentation, either in systemic or cutaneous form. Clinical signs include anorexia, ophthalmopathies, and chronic kidney disease. In the state of Santa Catarina, the foci are concentrated in the capital and its adjacencies, in the east side of the state.
Silveira, Nathalia Saynovich Dutra, Mendes, Eduarda Mariana, Pereira, Marcy Lancia, Tavela, Alexandre de Oliveira, Veiga, Angela Patricia Medeiros, Zimermann, Francielli Cordeiro   +5 more
openaire   +2 more sources

Perceived quality of life among Visceral Leishmaniasis and HIV coinfected migrant male-workers in Northwest Ethiopia: a qualitative study

BMC Public Health, 2017
Background There is paucity of data on quality of life as a dimension of treatment outcome among Visceral Leishmaniasis and HIV coinfected patients. This study sought to explore perceived quality of life among Visceral Leishmaniasis and HIV coinfected ...
Mekuriaw Alemayehu, Mamo Wubshet, Nebiyu Mesfin, Abebaw Gebayehu   +3 more
doaj   +1 more source

Diagnosis of visceral leishmaniasis [PDF]

Transactions of the Royal Society of Tropical Medicine and Hygiene, 2011
Leishmaniasis is a vector-borne disease with up to 350 million people at risk of infection worldwide. Among its different clinical manifestations, visceral is the most severe form. Since clinical features of visceral leishmaniasis (VL) mimic several other common diseases, accurate diagnosis is crucial as the treatment is associated with significant ...
Shyam Sundar, Anand Dayama, Pankaj Srivastava, Sanjana Mehrotra   +3 more
openaire   +3 more sources

ANÁLISE DOS FATORES QUE INFLUENCIAM A OCORRÊNCIA DA LEISHMANIOSE VISCERAL HUMANA

Cogitare Enfermagem, 2021
Objective: to analyze the factors that influence the occurrence of Human Visceral Leishmaniasis in the state of Paraíba, Brazil. Methods: ecological study, developed with data from 2012 to 2017, collected in a reference laboratory in the state and in the
Allan Batista Silva, Francisca Inês de Sousa Freitas, Clélia de Alencar Xavier Mota, Maria Eliane Moreira Freire, Hemílio Fernandes Campos Coêlho, Caliandra Maria Bezerra Luna Lima   +5 more
doaj   +1 more source

Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India [PDF]

, 2011
Reports on treatment outcomes of visceral leishmaniasis (VL)-human immunodeficiency virus (HIV) coinfection in India are lacking. To our knowledge, none have studied the efficacy of liposomal amphotericin B in VL-HIV coinfection.
Alvar, Bachani, Berman, Bern, Bora, Braitstein, C. Ferreyra, D. Remartinez, G. Mitra, Hurissa, Ikomi, J. van Griensven, K. Pandey, L. Flevaud, Lin, Lyons, M. Pece, Mathur, N. Kumar, N. Verma, P. Das, P. K. Sinha, P. Kumar, P. P. Palma, Pintado, R. Kumar, R. Mahajan, Redhu, Sinha, Sinha, Sundar, Sundar, ter Horst, Thakur, van Griensven   +34 more
core   +2 more sources

Leishmaniasis visceral en médula ósea

, 2016
Una mujer de 47 anos, fue evaluada en Emergencias con fiebre y pancitopenia, con velocidad de eritrosedimentacion en 160mm/h (0-20mm/h) y deshidrogenasa lactica en 980 U/L (140-280 U/L).
Max A. Méndez López, Jorge López Villegas   +1 more
semanticscholar   +1 more source